Outpatient Treatment for Streptococcal Pharyngitis in Adults
For adults with confirmed Group A streptococcal pharyngitis, prescribe penicillin V 500 mg twice daily or 250 mg four times daily for 10 days, or alternatively amoxicillin 500 mg twice daily for 10 days. 1
First-Line Treatment (No Penicillin Allergy)
Penicillin remains the gold standard treatment based on its proven efficacy, narrow spectrum, safety profile, and low cost. Penicillin-resistant Group A Streptococcus has never been documented. 1
Preferred options:
- Penicillin V: 500 mg twice daily OR 250 mg four times daily for 10 days (strong, high-quality evidence) 1
- Amoxicillin: 500 mg twice daily for 10 days (strong, high-quality evidence) 1
- Amoxicillin offers equivalent efficacy with better adherence due to twice-daily dosing
- Once-daily dosing (1000 mg) is also effective but represents broader spectrum coverage 1
Alternative if adherence is a concern:
- Benzathine penicillin G: 1,200,000 units intramuscularly as a single dose (for patients ≥27 kg) 1
- Guarantees complete treatment course but requires injection
Treatment for Penicillin-Allergic Patients
For non-anaphylactic penicillin allergy:
- Cephalexin: 500 mg twice daily for 10 days (strong, high-quality evidence) 1
- Cefadroxil: 1 gram once daily for 10 days (strong, high-quality evidence) 1
Recent network meta-analysis data from 2026 suggests cefdinir demonstrates superior early bacterial eradication (OR: 3.09) and early clinical response (OR: 2.01) compared to penicillin V 2, making it an excellent alternative when first-generation cephalosporins are unavailable.
For true anaphylactic penicillin allergy (avoid all beta-lactams):
- Clindamycin: 300 mg three times daily for 10 days (strong, moderate-quality evidence) 1
- Clarithromycin: 250 mg twice daily for 10 days (strong, moderate-quality evidence) 1
Critical Caveat: Avoid Azithromycin
Do not prescribe azithromycin for streptococcal pharyngitis. Despite its convenience as a 5-day course, azithromycin demonstrates:
- Inferior early bacterial eradication compared to penicillin V (OR: 0.53) 2
- Inferior late bacterial eradication (OR: 0.38) 2
- Higher bacteriological recurrence rates 2
- Significant geographic resistance patterns 1
- Increased adverse events 2
The 2024 American Family Physician review confirms significant resistance to azithromycin and clarithromycin in parts of the United States 3, making macrolides problematic choices despite their historical use.
Treatment Duration and Rationale
All regimens require 10 days of treatment (except azithromycin 5 days, which is not recommended, and single-dose benzathine penicillin G). This duration is necessary to:
- Prevent acute rheumatic fever 1
- Prevent suppurative complications (peritonsillar abscess, cervical lymphadenitis, mastoiditis) 1
- Reduce contagiousness and transmission 1
- Improve clinical symptoms 1
The rare but devastating complications of untreated streptococcal pharyngitis—including pulmonary-renal syndrome with potential mortality 4—underscore the importance of appropriate antibiotic therapy.
Important Clinical Considerations
Do not treat asymptomatic household contacts routinely, as antibiotic prophylaxis has not been shown to reduce subsequent GAS pharyngitis incidence and exposes patients to unnecessary adverse effects 1
Do not routinely perform follow-up testing after treatment unless special circumstances exist (e.g., history of rheumatic fever, outbreak situations) 1
Avoid amoxicillin-clavulanate as initial therapy—the addition of clavulanate provides no benefit for streptococcal pharyngitis and unnecessarily broadens the spectrum 5
Antimicrobial Stewardship
Standard penicillins should remain first-line therapy to support antimicrobial stewardship efforts 2. The 2024 review notes that 60% or more adults with sore throat are prescribed antibiotics despite only 10% having confirmed streptococcal infection 3, highlighting the importance of appropriate diagnostic testing before prescribing.